Compare TBLA & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TBLA | AORT |
|---|---|---|
| Founded | 2007 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.7B |
| IPO Year | N/A | 1996 |
| Metric | TBLA | AORT |
|---|---|---|
| Price | $3.21 | $34.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $5.00 | ★ $48.76 |
| AVG Volume (30 Days) | ★ 1.9M | 327.5K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 165.62 |
| EPS | N/A | ★ 0.21 |
| Revenue | N/A | ★ $298,836,000.00 |
| Revenue This Year | $7.63 | $14.20 |
| Revenue Next Year | $5.25 | $11.17 |
| P/E Ratio | ★ $42.36 | $162.83 |
| Revenue Growth | N/A | ★ 18.01 |
| 52 Week Low | $2.71 | $21.97 |
| 52 Week High | $4.65 | $48.25 |
| Indicator | TBLA | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 50.96 | 36.58 |
| Support Level | $3.16 | $30.24 |
| Resistance Level | $3.45 | $44.29 |
| Average True Range (ATR) | 0.09 | 1.37 |
| MACD | 0.03 | -0.05 |
| Stochastic Oscillator | 89.47 | 25.74 |
Taboola is a performance-based native advertising network designed to improve click-through rates and increase monetizable events for advertisers while generating yield for publisher websites. Taboola competes with Google, Amazon, and other advertising networks that display stories and products on websites. The company was founded in 2007 in Israel. It acquired Connexity, a retail advertising network, in 2021, and entered a partnership with Yahoo in 2022, in which it acquired exclusive native advertising rights over Yahoo digital properties in exchange for a 25% equity stake in the company.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.